Abinav Baweja recently graduated from UCLA with a B.S. in Molecular, Cell and Developmental Biology. As an undergraduate, Abinav studied regulation of ABL tyrosine kinases by the cellular regulator RIN1. He also applied drug screening and structural biology to help discover a new class of drugs to treat drug-resistant leukemias characterized by BCR-ABL oncogenic fusions. In the lab, he studied the functional roles of non-coding RNAs in oncogenesis. Abinav is now busy as a medical student at the UCLA David Geffen School of Medicine.
